Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
Alberta Stroke Program Early CT score
algorithm
anatomy of
anterior cerebral artery, occlusion of
anterior temporal branch of posterior cerebral artery
anticoagulant, treatment
anticoagulant, treatment in CVD
aphasia
apixaban
arterial dissection
artificial intelligence
asymptomatic
atrial fibrillation
AURORA
brain purpura
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, attenuation coefficient
CAT scan, dense artery sign
CAT scan, early changes in CVA
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, net water uptake
CAT scan, perfusion
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, bilateral
cerebrovascular accident, complications with
cerebrovascular accident, cryptogenic
cerebrovascular accident, delay in treatment
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, mimics
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, secondary prevention
cerebrovascular accident, seizure with
cerebrovascular accident, severity
cerebrovascular accident, silent
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular accident, young adult
children
clinical mismatch
clot retrieval
collateral circulation
complications
computers, handheld
computers, medicine and
computers, neurologic diagnosis and
contraindications
controversies in neurology
cortical infarction, small
cost
cost effectiveness
C-reactive protein
C-reactive protein, elevated
dabigatran
DAWN stroke trial
decision aids
decision analysis
DEFUSE study
dense middle cerebral artery sign
dense posterior cerebral artery sign
diagnosis related group
disability rating scale, neurological
doppler
doppler, transcranial
echocardiogram
echocardiogram, transesophageal
efficacy
embolism, paradoxical
emergency physician
endovascular therapy
endovascular therapy, futile interhospital transfer
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
evidence-based research
factor Xa inhibitor
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, exclusion criteria
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, utilization
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gastrointestinal bleeding
glucose level, serum
GOLIATH trial
hemianopia
hemianopia, homonymous
hemiparesis
hemiplegia
hemoglobin A1c
hippocampal infarction
idarucizumab
informed consent
interobserver agreement
intracerebral hemorrhage
intracerebral hemorrhage, volume
ischemic penumbra
lacunar infarction
large artery disease
lawsuit
malpractice
medical-legal aspects of neurology
menses
MERCI trial
microhemorrhage, intracerebral
middle cerebral artery
middle cerebral artery, occlusion of
mimics
misdiagnosis
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, angiography
MRI, angiography, contrast enhanced
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, gradient-echo
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic disease, diagnoses of
neurologic examination, fluctuating
neurologic examination, focal
neurologic signs
neuroradiology, interventional
NIH stroke scale
NIH stroke scale, fluctuating
non-vitamin K antagonist oral anticoagulants
number needed to treat
occipital lobe, infarction
old age, neurology of
patent foramen ovale
patent foramen ovale, surgical treatment of
patient information and support
patient selection
platelet count
platelet inhibiting drugs
posterior cerebral artery
posterior cerebral artery embolism
posterior cerebral artery territory infarction
posterior cerebral artery, fetal type
posterior fossa, lesion of
practice guidelines
pregnancy, neurologic complications in
prognosis
protocol violations
quality of life
Rankin score
RAPID CT perfusion maps
recanalization, arterial
reperfusion
Retriever Device
revascularization, surgical
review article
risk factors
risk-benefit assessment
rivaroxaban
safety
screening
SEDAN score
seizure
solitaire device
stroke center
stroke disability scale
stroke protocol
stroke, progression of
symptomatic
thalamus, infarction of
thrombectomy
thrombocytopenia
thrombolysis, mechanical
thrombus, atrial
time is brain
tissue plasminogen activator, intravenous
transport of patient
treatment of neurologic disorder
Trevo retriever
vasculopathy
visual field defect
visual impairment
visual loss
WAKE-UP trial
workup
Showing articles 100 to 150 of 3165 << Previous Next >>

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005

Progressive Myoclonic Epilepsies: A Review of Genetic and Therapeutic Aspects
Lancet Neurol 4:239-248, Shahwan, A., et al, 2005

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis
Stroke 33:95-98, Kidwell,C.S.,et al, 2002

Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992

Diagnosis of Epilepsy
Lancet 336:291-295, Chadwick,D., 1990

Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026

CT Perfusion Abnormality in Hypoglycemic Focal Neurological Deficits
Stroke 57:e6-e7, Mikito,S.,et al, 2026

Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026

Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026

Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026

Intranasal Selectracetam in a Patient with Reading Epilepsy:First-In-Human Use to Prevent Reflex Seizures
Ann Neurol 99:535-539, Koepp,M.J.,et al, 2026

Turning Slowly Predicts Future Diagnosis of Parkinsons Disease:A Decade-Long Longitudinal Analysis
Ann Neurol 99:114-123, Elshehabi,M.,, 2026

Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026

Unilateral Primary Angiitis of the Central Nervous System: A Rare and Under-Recognized Entity
AJNR 47:589-595, Rai,P.,et al, 2026

Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026

Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026

Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome
JAMA Neurol 83:250-258, Lim,T.R.et al, 2026

Polymyalgia Rheumatica
NEJM 394:1097-1109, Dejaco,C.,et al, 2026

Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026

Frequency of AQP4 and MOG Antibodies in Patients with Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria
Neurol 106:e214753, Deschamps,R.,et al, 2026

The 2024 McDonld Criteria for Dignosis of Multiple Sclerosis, The Rubber meets the Road
Neurol 106:e214688, Miller, A.E., 2026

Comparison of AI, Diagnostic Generator, and Expert Opinion in Difficult Neurologic Diagnosis; Real-World Case Study
Diagnosis doi.org/10.1515/dx-2026-002, Finelli,P.F., 2026

Diagnostic Value of the Kappa Free light Chain Index to Distinguish MOGAD, NMOSD, and MS
Neurol 106:e214946, Tournier,A.,et al, 2026

Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026

Large Language Model Performance and Clinical Reasoning Tasks
JAMA Netw Open 9:e264003, Rao,A.S.,et al, 2026

Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026

Can AI Say "I Dont Know"?
NEJM 394:1873-1875, Sikora,A.,et al, 2026

Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026

Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026

Inflammatory Myopathies
NEJM 394:1925-1938, AllenBach,Y. & Benveniste,O., 2026

Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings
AJNR 47:513-520, Bruen,R.,et al, 2026

Neurological History Both Twinned and Queried by Generative Artificial Intelligence
Front Med doi.10.3389/frmed.2024.1496866, Lee,J-H.,et al, 2025

Niemann-Pick Disease Type C
Gene Reviews www.genereview.org, Bremova-Ertl,T. & Patterson, M., 2025

High-Grade Gliomas with Autoimmune Encephalitis-Like Presentation: Case Report and Systematic Review of the Literature
Neurological Sci 46:3559-3572, Creda,G.S.et al, 2025

Myelin Oligodendrocyte Glycoprotein Antibody - Associated Cerebral Cortical Encephalitis: A Case Report Highlighting Diagnostic Challenges and Therapeutic Implications
Front Immunol 16:1619807, Liu,M. & Li, D., 2025

AI: Need for Comparative Studies in Complex Neurologic Diagnosis
Ann Neurol doi:10.1002/ana.78068, Finelli,P.F., 2025

Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion:An Individual Participant Data Meta-Analysis
Stroke 56:3175-3186, Xie,J.S.,et al, 2025

Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke:A Multicenter Real-World Study
Stroke 56:3187-3198, Xiao,Y.,et al, 2025

Neurosyphilis
Ann Neurol 98:1070-1076, Minter,D.J. & Chow,F.C., 2025

Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025



Showing articles 100 to 150 of 3165 << Previous Next >>